New chemical to treat koalas with chlamydia


Tuesday, 30 August, 2016

New chemical to treat koalas with chlamydia

Australian scientists have announced a breakthrough in their quest for a new drug to treat koalas suffering from chlamydia. Writing in the journal Nature Scientific Reports, they report the discovery of a chemical that is paving the way for a new life-saving antibiotic.

Male and female koalas are affected by two species of chlamydia — C. pecorum and C. pneumoniae. The first causes eye disease, including inflammation and discharge, or urogenital disease, including cystitis, urinary incontinence and fibrosis, which can cause infertility. The second strain causes severe respiratory illness.

Koalas are responding poorly to antibiotic treatments commonly used in humans, suffering side effects such as emaciation and typically failing to recover completely from disease. Specialist koala vets are using two antibiotics — Baytril and Chloramphenicol 150 — however, there is less than two years’ supply of Chloramphenicol 150 remaining and neither of the current treatments works in all cases of chlamydial disease.

“Manufacture has stopped, supply has stopped and it can take years to develop a new drug,” said Dr Willa Huston from the University of Technology Sydney. “We are in a desperate search to find new, effective treatments and test other drugs that might help koalas recover from this horrible disease.”

Now, Dr Huston and collaborators from the Queensland University of Technology, Australia Zoo Wildlife Hospital and elsewhere have identified a chemical that paves the way for a new antibiotic to save koalas’ lives. The inhibitor, JO146, targets the serine protease HtrA for treatment of C. pecorum and C. pneumoniae in vitro and ex vivo.

In extensive laboratory tests on tissue samples from chlamydia-infected koalas, the team found the inhibitor to be highly successful at killing both C. pecorum and C. pneumoniae bacteria. Furthermore, it was low in toxicity against koala cells.

“It’s really urgent now that we put a concerted effort into developing this treatment further,” said Dr Huston, whose team is currently fine-tuning the chemical make-up of their discovery before testing on sick koalas.

“Time is running out. We all treasure our koalas and we need to do everything we can to cure this disease.”

Image caption: A koala with chlamydial eye disease is examined by vets. Image credit: Willa Huston.

Related News

High-potency cannabis use leaves a unique mark on DNA

Frequent users of high-potency cannabis have changes in genes related to mitochondrial and immune...

Scaffold-based method for culturing antitumour bacteria

Bacteria-based cancer therapy represents an exciting new treatment option — but in order to...

mpox vaccine appears safe and effective in adolescents

Interim analysis of an mpox vaccine trial has found the vaccine is safe in adolescents and...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd